Data spanning the past 90 days through February 07, 2026 reveals that United Therapeutics's three principal insider shareholders consist of Evp & General Counsel Paul A Mahon (36.78K shares), Director Richard Giltner (20.57K shares), Director Ray Kurzweil (12.67K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Paul A Mahon | Evp & General Counsel | 36,781 | 05 Feb, 2026 |
| Richard Giltner | 20,574 | 28 Jul, 2025 | |
| Ray Kurzweil | 12,670 | 28 Jul, 2025 | |
| Martine A Rothblatt | Chairperson & Ceo | 11,092 | 19 Dec, 2025 |
| Tommy G Thompson | 8,480 | 19 Dec, 2025 | |
| James Edgemond | Cfo And Treasurer | 8,142 | 16 Dec, 2025 |
| Nilda Mesa | 5,286 | 10 Dec, 2025 | |
| Judy D. Olian | 5,045 | 19 Sep, 2025 | |
| Christopher Causey | 4,190 | 06 Jan, 2026 | |
| Katherine J Klein | 3,640 | 11 Mar, 2024 | |
| Louis W Sullivan | 3,200 | 19 Dec, 2024 | |
| Christopher Patusky | 2,590 | 16 Dec, 2025 | |
| Michael Benkowitz | President And Coo | 2,577 | 07 May, 2024 |
| Raymond Dwek | 1,750 | 22 Apr, 2025 | |
| Jan Malcolm | 270 | 03 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 477 | $480.92 | 44,604 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 675 | $485.52 | 36,781 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 2,363 | $481.93 | 42,241 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 934 | $484.92 | 37,456 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 1,103 | $482.57 | 41,138 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | D | 2,748 | $483.92 | 38,390 | D | S |
| 05 Feb, 2026 | Paul A Mahon | Common Stock | A | 8,300 | $146.03 | 45,081 | D | M |
| 03 Feb, 2026 | Jan Malcolm | Common Stock | D | 50 | $474.23 | 270 | D | S |
| 02 Feb, 2026 | Michael Benkowitz | Common Stock | A | 14,625 | $117.76 | 14,625 | I | M |
| 02 Feb, 2026 | Michael Benkowitz | Common Stock | D | 7,875 | $470.95 | 0 | I | S |
| 02 Feb, 2026 | Michael Benkowitz | Common Stock | D | 14,625 | $470.95 | 0 | I | S |
| 02 Feb, 2026 | Michael Benkowitz | Common Stock | A | 7,875 | $146.03 | 7,875 | I | M |
| 26 Jan, 2026 | Michael Benkowitz | Common Stock | A | 14,625 | $117.76 | 14,625 | I | M |
| 26 Jan, 2026 | Michael Benkowitz | Common Stock | D | 7,875 | $471.91 | 0 | I | S |
| 26 Jan, 2026 | Michael Benkowitz | Common Stock | A | 7,875 | $146.03 | 7,875 | I | M |
| 26 Jan, 2026 | Michael Benkowitz | Common Stock | D | 14,625 | $471.91 | 0 | I | S |
| 20 Jan, 2026 | Michael Benkowitz | Common Stock | D | 837 | $469.18 | 182 | I | S |
| 20 Jan, 2026 | Michael Benkowitz | Common Stock | D | 2,922 | $468.12 | 1,019 | I | S |
| 20 Jan, 2026 | Michael Benkowitz | Common Stock | D | 1,055 | $466.06 | 4,537 | I | S |
| 20 Jan, 2026 | Michael Benkowitz | Common Stock | D | 498 | $459.87 | 12,619 | I | S |